Test For Alzheimer S May Be Undermining Drug Trials
The scientists published their findings in two papers in the journal Alzheimer’s & Dementia. In the past two years, there have been a number of clinical trials producing disappointing results for high-profile drugs, making some pharmaceutical companies abandon Alzheimer’s altogether. The flaws in the ADAS-Cog test could be partly responsible. The ADAS-Cog test has been used as a key indicator on whether a drug is working. The test scores patients on 11 components using a variety of tasks associated with memory, language and praxis....